Tofacitinib in refractory non-infectious anterior uveitis: a retrospective observational study
Tofacitinib was associated with high rates of remission and rapid corticosteroid withdrawal in refractory non-infectious anterior uveitis, with no serious adverse events over 12 months, hypothesis-generating and require confirmation in controlled prospective studies before tofacitinib can be positioned relative to esta...